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Abnormal gut-associated lymphoid tissue (GALT) in
humans is associated with infectious and autoim-
mune diseases, which cause dysfunction of the
gastrointestinal (GI) tract immune system. To aid
in investigating GALT pathologies in vivo, we bio-
engineered a human-mouse chimeric model char-
acterized by the development of human GALT
structures originating in mouse cryptopatches. This
observation expands our mechanistic understand-
ing of the role of cryptopatches in human GALT
genesis and emphasizes the evolutionary con-
servation of this developmental process. Immuno-
globulin class switching to IgA occurs in these
GALT structures, leading to numerous human IgA-
producing plasma cells throughout the intestinal
lamina propria. CD4+ T cell depletion within GALT
structures results from HIV infection, as it does in
humans. This human-mouse chimeric model repre-
sents the most comprehensive experimental plat-
form currently available for the study and for the
preclinical testing of therapeutics designed to repair
disease-damaged GALT.INTRODUCTION
The mammalian gastrointestinal (GI) tract contains a well-
organized immune system consisting of the gut-associated
lymphoid tissues (GALTs) and the diffuse intestinal lamina
propria. GALT includes Peyer’s patches (PPs) and isolated
lymphoid follicles (ILFs) where antigen-primed T and B cells
are activated. These cells then migrate into the lamina propria
where protective immune responses against invasive microor-
ganisms and pathogenic toxins occur (McGhee et al., 2007;
Pabst, 2012). GALT and lamina propria are distinct tissues
that together form the GI tract immune system that is criti-
cally important in the maintenance of health by providing a
protective barrier between the host and a GI microbial
ecosystem (Hooper and Macpherson, 2010; Pabst, 2012). A
key component of this activity is IgA production because
this molecule inhibits bacterial penetration into intestinal tis-
sue and aids in the maintenance of symbiotic relationships1874 Cell Reports 3, 1874–1884, June 27, 2013 ª2013 The Authorsformed between beneficial commensal microbiota and the
host (Hooper and Macpherson, 2010; McGhee et al., 2007;
Pabst, 2012). Because a functional GALT is an essential
component of the GI tract immune system, immune dysfunc-
tions associated with abnormalities of the GALT lead to major
health concerns (Brenchley and Douek, 2008; Khor et al.,
2011). For example, HIV infection causes massive CD4+
T cell depletion in the GI tract immune system (Brenchley
and Douek, 2008; Mehandru et al., 2004). The resulting
dysfunction has been linked to abnormal microbial transloca-
tion and immune activation, resulting in increased morbidity
and mortality in HIV-infected individuals (Brenchley et al.,
2006). Inflammatory bowel diseases (IBDs) (i.e., ulcerative co-
litis and Crohn’s disease) also have major physical manifesta-
tions that cause long-term patient distress (Khor et al., 2011)
due primarily to overactive GALT (e.g., anomalous hyperpla-
sia of ILFs that leads to excess production of the proinflam-
matory tumor necrosis factor [TNF]-a) (Yeung et al., 2000).
Successfully achieving our goal of generating an in vivo xeno-
graft model characterized by the presence of human GALT
would greatly benefit research focused on gaining a compre-
hensive understanding of the mechanisms that lead to these
GALT pathologies. Furthermore, the availability of such a
model would fill a critical need for an in vivo experimental
platform for preclinical efficacy testing of therapeutic
interventions to treat infectious and autoimmune disease-
induced GALT pathologies.
In mice, the molecular and cellular mechanisms by which
GALT develops have been extensively characterized. ILF for-
mation is environmentally induced postnatally by commensal
microbiota and requires cryptopatches containing lymphoid
tissue inducer (LTi) cells—a distinct population of group 3 innate
lymphoid cells (Eberl, 2005; Lorenz et al., 2003; Spits et al.,
2013; van de Pavert and Mebius, 2010). During ILF genesis,
intestinal epithelial cells produce IL-7 that signals via the IL-7
receptor on LTi cells to induce the expression of lymphotoxin
a1b2 (LT-a1b2) (Eberl, 2005; van de Pavert and Mebius, 2010).
LT-a1b2 binds to the lymphotoxin b receptor (LTbR) on resident
lymphoid tissue organizer (LTo) cells to upregulate the expres-
sion of chemokines (e.g., CXCL13, CCL19, and CCL21) and
adhesion molecules (e.g., VCAM1 and ICAM1) for the recruit-
ment and retention of lymphocytes into the cryptopatches
(Eberl, 2005; van de Pavert and Mebius, 2010). This cell-to-
cell signaling cascade reveals that IL-7R signaling is absolutely
essential for GALT genesis such that normal GALT development
fails to occur in mice with impaired IL-7R signaling, including
(legend on next page)
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IL-7Ranull mice and mice lacking the common g chain (IL-2Rgnull
mice) (Hamada et al., 2002; Ivanov et al., 2006).
In contrast to our significant knowledge of GALT genesis in
mice, this process is poorly understood in humans. Crypto-
patches have been considered absent in humans (Moghaddami
et al., 1998; Pabst et al., 2005); however, a recent histological
study revealed the presence of cryptopatch-like structures in
human gut (Lu¨gering et al., 2010). This key observation led
us to test whether mouse cryptopatches could serve as
anlagen for human GALT genesis using a chimeric model.
For these studies, we used bone marrow-liver-thymus (BLT)
humanized mice (Denton et al., 2012; Lan et al., 2006; Melkus
et al., 2006) constructed in two closely related, lymphocyte-
lacking, immunodeficient mouse strains that differ in their
ability to develop cryptopatches (i.e., NOD/SCID (N/S] and
NOD/SCID IL-2Rgnull [NSG]). Specifically, N/S mice have
cryptopatches, whereas NSG mice lack these structures
because of the absence of a functional IL-2Rg chain. We
hypothesized that the cryptopatches of N/S mice could
serve as anlagen for the development of human GALT in BLT
humanized N/S (N/S-BLT) mice. Accordingly, we show that
human GALT structures develop in the host cryptopatches of
N/S-BLT mice. Moreover, HIV infection of N/S-BLT mice
results in specific human CD4+ T cell depletion in the GALT
structures. These observations highlight the potential of this
model for the study of human GALT development in vivo and
for performing preclinical evaluation of therapeutic interven-
tions designed to treat important GALT-associated clinical
conditions.
RESULTS
Cryptopatches Containing LTi Cells, the Anlagen for
GALT Genesis, Are Present in N/S but Not NSG Mice
To establish a baseline for GALT genesis in N/S and NSG
mice, we examined the GI tract of nonhumanized mice.
Immunocompetent BALB/c mice were used as a reference
and positive control for the identification of cryptopatches
and other relevant GALT structures in mice. We found that
cryptopatches develop between the intestinal crypts in N/S,
but not NSG, mice (Figure 1A). Immunofluorescence analysis
(IFA) revealed that N/S and BALB/c mouse cryptopatches
contain mouse IL-7Ra (mIL-7Ra)
+ cells and mCD11c
+ dendriticFigure 1. Hematopoietic Cells and Structures within the SIs of N/S, NS
H&E (A) and IFA (B) images of SIs from N/S (top), NSG (center), and BALB/c (bo
cryptopatches in N/S and BALB/c mice. N/S mouse cryptopatches can become e
are morphologically similar to BALB/c mouse GALT (i.e., ILFs and PPs). (B) IFA rev
in N/S mice. Corner images present higher magnification minus DAPI. Scale bar
(C and D) Flow cytometry analyses of the intestinal lamina propria from N/S and N
immunodeficient mouse strains and their presence in BALB/c mice. Representa
isolations were performed under the same conditions, and equal numbers of eve
(E and F) mCD45
+
mLin
neg
mIL-7Ra
+
mc-kit
+ innate lymphoid cells are present in the
lymphoid cells in the SI lamina propria were identified via flow cytometry (n = 3, e
Pairs of middle panels present mCD45
+
mLin
neg cells examined for mIL-7Ra and
fluorescence. Representative plots from one mouse of three analyzed per strain. (
Student’s t test was used to confirm the statistical significance of the difference in
mice (n = 3 per strain).
See also Figure S1.
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lymphoid cells typically expand cryptopatches into ILFs (Eberl,
2005; Eberl and Littman, 2004; van de Pavert and Mebius,
2010). Interestingly, although N/S and NSG mice lack mouse
T and B cells (Shultz et al., 2005) (Figures 1B–1D), the crypto-
patches in N/S mice become enlarged with a follicle-associated
epithelium that is morphologically similar to BALB/c mouse
GALT (e.g., ILFs and PPs) (Figure 1A). These enlarged struc-
tures in N/S mice contain mIL-7Ra
+ cells and mCD11c
+
dendritic cells, and they lack the lymphoid follicles composed
of mCD3
+ T and mB220
+ B cells that are found in BALB/c
mouse GALT (Figure 1B). We used polychromatic flow cytom-
etry to analyze cells isolated from small intestines (SIs) of
these mice. Within the mouse lineage marker (mCD3, mB220,
mCD11b, mGr-1, and mTER-119) negative population, we
identified mIL-7Ra
+
mc-kit
+ innate lymphoid cells in N/S and
BALB/c, but not NSG, mice (Figures 1E and 1F). Further
examination of the mIL-7Ra
+
mc-kit
+ innate lymphoid cells
revealed that a small fraction of this population also expressed
mCD4, which defined these cells as LTi cells (Spits et al., 2013)
(Figure S1A). However, the majority of the mIL-7Ra
+
mc-kit
+
population also expressed mNKp46
+, which defined these cells
as a separate subset of group 3 innate lymphoid cells known as
natural cytotoxicity-triggering receptor (NCR)+ cells (Figure S1A)
(Spits et al., 2013). These cells were primarily located in the
lamina propria of N/S mice and were not present in NSG
mice (Figure S1B). Together, these results demonstrate that
N/S mice have cryptopatches containing LTi cells that could
serve as potential anlagen for the development of human
GALT in their GI tract.
Reconstitution of N/S-BLT and NSG-BLT Mice
with Human Hematopoietic Cells
For our study, we utilized 26 BLT mice exhibiting comparable
systemic humanization (N/S-BLT, n = 13; NSG-BLT, n = 13).
Specifically, the average percentage of hCD45
+ cells in the
peripheral blood of N/S-BLTmice was 52% (±20%SD), of which
71% (±21% SD) was hCD3
+ T cells, and 15% (±19% SD) was
hCD19
+ B cells. Similarly, the average percentage of hCD45
+
cells in the peripheral blood of NSG-BLT mice was 71%
(±13% SD), of which 80% (±18% SD) was hCD3
+ T cells,
and 9% (±14% SD) was hCD19
+ B cells. Systemic reconstitu-
tion with human hematopoietic cells in peripheral tissuesG, and BALB/c Mice
ttom) mice are shown. Corner images in (A) present high magnification of the
nlarged with defined follicle-associated epithelium giving rise to structures that
ealed the expected absence of mouse T and B cells in the cryptopatches found
s, 100 mm.
SG mice confirmed the absence of mCD3
+ T cells and mCD19
+ B cells in these
tive flow plots (C) and cumulative data (D) are shown (n = 3 per strain). All cell
nts were collected per sample.
SI lamina propria of both N/S and BALB/c mice, but not NSG mice. (E) Innate
ach strain). Far-left panels show lineage cocktail isotype control fluorescence.
mc-kit expression. Far-right panels show mIL-7Ra and mc-kit isotype control
F) Quantification of the absolute numbers of innate lymphoid cells is presented.
the number of mLin
neg
mIL-7Ra
+
mc-kit
+ cells present in N/S, NSG, and BALB/c
Figure 2. Endogenous Cryptopatches, Devoid of Mouse Lympho-
cytes, Mature into Expanded Immune Aggregates in the SIs of N/S
Mice following BLT Humanization
(A) Representative low-magnification images of H&E lower SIs (ileum, 6 cm
long when embedded) of nonhumanized and BLT-humanized N/S and NSG
mice. Cryptopatches (blue arrowheads) are present in the SIs of both non-
humanized and BLT-humanized N/S mice. In addition, expanded immune
aggregates (red arrows) are observed in N/S-BLT mice. High-magnification
images illustrate a representative enlarged cryptopatch and an expanded
immune aggregate in N/S-BLT mice. Also shown are intestinal villi from NSG-
BLT mice. Scale bars, 250 mm.
(B) IFAs show that the enlarged cryptopatches in nonhumanized N/S mice
harbor only mCD45
+ cells (green, left panel in the top row), whereas in N/S-BLT
C(e.g., spleen, liver, lung) was comparable between N/S-BLT and
the NSG-BLT mice (data not shown; Denton et al., 2012). There-
fore, these two types of BLT mice, one with and one without
cryptopatches, were specifically chosen to test our hypothesis
that cryptopatches can serve as suitable anlagen or foundation
for human GALT development.
Development of Human GALT Structures in N/S-BLT
Mice
When we examined the GI tract immune system in N/S-BLT and
NSG-BLT mice, we noted that expanded immune aggregates
were present in the SIs of 13 of 13 N/S-BLT mice, whereas
none was present in the SIs of 13 NSG-BLT mice (Figure 2A)
(p < 0.0001, Fisher’s exact test). This highly reproducible obser-
vation was consistent with our hypothesis. Polychromatic flow
cytometry analysis with cells isolated from the SIs of N/S-BLT
humanized mice revealed that human group 3 innate lymphoid
cells (hCD3
neg
hCD4
neg
hCD45
+
hIL-7Ra
+
hc-kit
+; Spits et al.,
2013) are present, albeit in very small numbers (Figure S1C).
IFA of the immune aggregates present in the SIs revealed that
hCD45
+ cells accumulated into cryptopatches together with
mCD45
+ cells (Figure 2B). As they expanded, these lymphoid
aggregates harbored greater numbers of hCD45
+ cells than
mCD45
+ cells (Figure 2B). Moreover, the human hematopoietic
lineages present in expanded lymphoid aggregates included
hCD3
+ T cells, hCD19
+ B cells, hCD11c
+ dendritic cells, and
hCD68
+ macrophages (Figure 3A), defining these as human
GALT structures (Jung et al., 2010). The specificity of all the
antibodies to human antigens used in our analyses was carefully
confirmed by parallel staining of tissues obtained from non-
humanized N/S and NSG mouse intestines (data not shown). In
summary, the presence or absence of cryptopatches in the
two different strains used to generate BLT mice corresponded
directly to the presence or the lack of human GALT structures.
Comprehensive Characterization of the GI Tract Human
Immune Reconstitution in BLT Mice
The GI tract immune system consists of multiple compartments:
GALT, diffuse lamina propria, and an epithelial cell monolayer
harboring intraepithelial lymphocytes (McGhee et al., 2007;
Pabst, 2012). GALT is where mature naive B cells differentiate
into class-switched IgA+ cells that localize to the intestinal lamina
propria (McGhee et al., 2007; Pabst, 2012). Intraepithelial lym-
phocytes in N/S-BLT mice include human CD8+ T cells, CD4+
T cells, natural killer cells, and myeloid dendritic cells, but not
gd T cells (Sun et al., 2007). The difference observed in the ability
of humanGALT to develop in N/S-BLT versus NSG-BLTmice led
us to hypothesize that this difference would influence the human
immune cell lineages present in the mouse intestinal lamina
propria. Therefore, we performed flow cytometry analyses on
cells isolated from SIs. We found equivalent numbers of hCD3
+mice, there is an accumulation of hCD45
+ cells (red, center panel) alongside the
mCD45
+ cells (middle row). The relative proportion of hCD45
+ cells to mCD45
+
cells shifts dramatically as cryptopatches expand to become immune aggre-
gates (bottom row). The imagesmerged with a DAPI-counterstained image are
shown on the right. Scale bars, 50 mm.
See also Figure S1.
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Figure 3. The Distribution of hCD19
+ B Cells in the SIs of N/S-BLT
Mice Is Restricted to GALT Structures
(A) Expanded immune aggregates of N/S-BLT mice were defined as human
GALT structures by the presence of hCD3
+ T cells, hCD19
+ B cells, hCD11c
+
dendritic cells, and hCD68
+ macrophages.
(B and C) Flow cytometry analyses show equivalent numbers of hCD3
+ T cells
in the SIs of N/S-BLT (n = 4) and NSG-BLT (n = 4) mice. In contrast, the
absolute number of hCD19
+ B cells in the SIs of N/S-BLT mice is higher versus
NSG-BLT mice (Student’s t test; N.S., not significant). Gating indicates
lymphoidhCD45
+
hCD3
+ or hCD19
+. Data represent mean ± SEM.
(D) The lack of human GALT structures in NSG-BLT mice limits direct com-
parison to the intestinal villi of the two types of BLT mice. Scale bars, 50 mm.
See also Tables S1, S2, and S3.T cells in both types of BLTmice (Figures 3B and 3C). In contrast,
the number of hCD19
+ B cells was significantly higher in N/S-BLT
versus NSG-BLT mice (Figures 3B and 3C).
We next used IFA to characterize the human immune cells in
the intestinal lamina propria of BLT mice. In comparison to the
relative abundance of human B cells present in the GALT struc-
tures of N/S-BLT mice, hCD19
+ B cells were infrequent in the1878 Cell Reports 3, 1874–1884, June 27, 2013 ª2013 The Authorslamina propria of both N/S-BLT and NSG-BLT mice (Figure 3D).
In contrast, hCD3
+ T cells, hCD11c
+ dendritic cells, and hCD68
+
macrophages were identified here in both types of BLT mice
(Figure 3D). The restricted distribution of human B cells in the
human GALT structures of N/S-BLT mice was confirmed using
a second pan B cell marker, hCD20 (Figure S2A).
The pan B cell surface markers (CD19 and CD20) are appro-
priate to study the distribution of human B cells at most stages
of differentiation; however, the reduction or disappearance of
these markers on fully differentiated B cells precludes their utili-
zation to determine the presence of plasma cells (Benckert et al.,
2011; Farstad et al., 2000). Therefore, other B cell differentiation
markers were used to investigate the intestinal plasma cells in
N/S-BLTmice. In theGALT structures, we found cells expressing
humanactivation-inducedcytidinedeaminase (AID) (FigureS2A).
This observation is consistent with the presence of class-
switched hIgA
+ and hIgG
+ cells (Figure S2A). In addition, hIgM
+
cells were also found in these structures (Figure S2A). The anti-h
IgM antibody (Taylor and Burns, 1974) used for this IFA is
strongly reactive with plasma cells producing hIgM, but not
with mature naive B cells bearing surface hIgM, defining the
hIgM
+ cells found in the GALT structures as unswitched hIgM-
producing plasma cells.
To investigate the maturation of B cells to hIgA-producing
plasma cells, we performed additional IFAs. We found that all
hIgA
+ cells were consistently negative for hCD20 expression,
whereas some hIgA
+ cells expressed HLA-DR, another mature
naive B cell marker (Farstad et al., 2000) (Figure S2B). hCD27,
hCD38, or hCD138 was also expressed on some hIgA
+ cells,
confirming their status as fully differentiated plasma cells
(Figure S2B) (Farstad et al., 2000). These results indicate that
the human GALT structures contain heterogeneous hIgA
+ cell
populations at multiple differentiation stages. Quantitative IFA
revealed that the SI lamina propria of N/S-BLT mice harbors
more hCD45
+
hIgA
+ cells versus hCD45
+
hIgM
+ cells or hCD45
+
h
IgG+ cells (Figures 4A and 4B). In contrast, very few hCD45
+ cells
expressing hIgA, hIgM, or hIgGwere found in NSG-BLTmice (Fig-
ures 4A and 4B). These results confirmed our hypothesis that the
presence of most human plasma cells in the intestinal lamina
propria of BLT mice is dependent on the presence of human
GALT structures. Furthermore, the fact that N/S-BLT mice
have cryptopatches (Figure 2), together with the fact that intrae-
pithelial T cell numbers are significantly higher in N/S-BLT mice
relative to NSG-BLT mice (Denton et al., 2012), suggests
that intraepithelial lymphocyte reconstitution is partially crypto-
patch/GALT dependent.
Despite the absence of GALT structures in NSG-BLT mice,
their lamina propria contained a small number of hCD45
+
hIg
+
cells (Figures 4A and 4B). We hypothesized that the presence
of human cells in the gut-draining mesenteric lymph nodes
(MLNs) could explain this observation. Our hypothesis was
based on the following key facts: (1) both GALTs and MLNs
are sites where human IgA+ cells, in addition to T cells, are pro-
grammed to migrate into the intestinal lamina propria (Mora and
von Andrian, 2009); (2) a functional IL-7R is dispensable for the
development of MLN anlagen (Cao et al., 1995); and (3) cryp-
topatch formation is completely dependent on IL-7R signaling
(Kanamori et al., 1996). We found that the MLNs in both
(legend on next page)
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N/S-BLT and NSG-BLT mice are similarly reconstituted with
hCD3
+ T cells, hCD19
+ B cells, hCD11c
+ dendritic cells, and
hCD68
+macrophages (Figure S3).We also found class-switched
hIgA
+ and hIgG
+ cells and unswitched hIgM
+ cells in the MLNs of
both types of BLT mice (Figure S3). These results are consistent
with our hypothesis that hIg
+ cells in the lamina propria of NSG-
BLT mice could originate from the MLNs.
IgA1- and IgA2-Secreting Plasma Cells in the Lamina
Propria of N/S-BLT Mice
A hallmark of the human GI tract immune system is the secretion
of IgA in the intestinal lamina propria (McGhee et al., 2007; Pabst,
2012). We used ELISPOT analyses to quantitate the antibody-
secreting plasma cells in the SIs of N/S-BLT and NSG-BLT
mice. N/S-BLT mice harbored more hIgA-secreting plasma
cells than hIgG-secreting plasma cells (Figures 5A and 5B). In
contrast, NSG-BLT mice had few plasma cells secreting hIg in
general and fewer plasma cells secreting hIgA and hIgG versus
N/S-BLT mice (Figures 5A and 5B). Consistent with human
data (Farstad et al., 2000), we found that hIgA
+ cells in the SI lam-
ina propria of N/S-BLT mice exhibited a surface expression
profile indicative of fully differentiated human plasma cells (i.e.,
hCD20
negHLA-DRneghCD27
+
hCD38
+
hCD138
+) (Figure 5C). In
humans, there are two IgA subclasses: hIgA1 and hIgA2 (Mes-
tecky et al., 1999). Like in humans, both are present in the
GALT structures and the intestinal lamina propria of N/S-BLT
mice (Figures 5D and S4). Together, these results emphasize
similarities between theN/S-BLT and the humanGI tract immune
systems, indicating that N/S-BLT mice are suitable for the study
of GALT pathologies.
GALT Destruction in N/S-BLT Mice after HIV Infection
HIV infection results in a catastrophic loss of CD4+ T cells in the
GI tract that is not fully reflected in the periphery (Brenchley and
Douek, 2008). Analysis of the human T cells in the GALT struc-
tures of N/S-BLT mice showed that, like in healthy humans
(Mehandru et al., 2004), there is a preponderance of CD4+
T cells. Specifically, the CD4/CD8 T cell ratio in the GALT struc-
tures of N/S-BLTmice was 1.84 (±0.19 SD), well within the range
(1.6–3.1) reported for healthy human GALT (Mehandru et al.,
2004). After rectal exposure, HIVgagp24-expressing cells are pre-
sent in the GALT structures of N/S-BLT mice (Figure S5A). Our
results show a 7.6-fold reduction in the number of hCD4
+
T cells in the GALT structures of these mice due to HIV infection
(Figure S5B), which is consistent with our previous flow cytome-
try-based observation that HIV infection decreased hCD4
+
T cells in the intestinal lamina propria and intraepithelial compart-
ments (Denton et al., 2008; Sun et al., 2007). In contrast, there
was no observed difference in hCD8
+ T cell levels in HIVneg
versus HIV+ animals (Figure S5C). Consistent with HIV patientFigure 4. SI Lamina Propria of N/S-BLT Mice Exhibits a Large Number
(A) SIs of both N/S-BLT (n = 4) and NSG-BLT (n = 4) mice were stained with anti-hI
merged images with a DAPI-counterstained image are shown in the right panel. H
images. Scale bars, 50 mm.
(B) Images similar to those in (A) from four mice per group were digitally conver
expressing either hIgM or hIgG or hIgA. (Student’s t test; lines connect compared
See also Figures S2 and S3.
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+ cells were significantly
increased in the GALT structures of HIV+ N/S-BLT mice (Fig-
ure S5D). These findings highlight the accurate manner in which
N/S-BLT mice recapitulate CD4+ T cell depletion in the GALT
structures.
Overall, these results support the following model for the
development of human GALT structures in N/S-BLT mice. First,
endogenous cryptopatches are populated with mouse LTi cells
that provide an appropriate local microenvironment for the
recruitment of human hematopoietic cells. Then recruited human
CD4+ T cells, CD8+ T cells, B cells, dendritic cells, and macro-
phages develop human GALT structures. Human B cells in these
structures express AID and differentiate into IgA-producing
plasma cells that migrate to the intestinal lamina propria. Once
established, these GALT structures are susceptible to HIV-
induced depletion of hCD4
+ T cells, further demonstrating how
human GALT structures in N/S-BLT mice recapitulate key phe-
notypes of human GALT during health and disease.
DISCUSSION
The human GI tract immune system is critically important in the
defense against intestinal pathogens and the maintenance of
immune tolerance to commensal microorganisms (Hooper and
Macpherson, 2010; McGhee et al., 2007; Pabst, 2012). These
activities represent a delicate balance that is susceptible to
disruption in patients with GALT-damaging infectious or autoim-
mune diseases (Brenchley and Douek, 2008; Khor et al., 2011).
In vivo studies of GALT genesis, biology, and pathology have sig-
nificant difficulties that are intrinsic to human studies. Reproduc-
ing human GALT biology using ex vivo organ cultures has proven
to be challenging (Hicks et al., 1996). If available, an in vivo xeno-
graft model that recapitulates human GALT development and
pathologies could offer the following advantages to GALT
research: (1) much longer experimental window (>6 months)
(Denton et al., 2008) relative to ex vivo approaches (48 hr)
(Hicks et al., 1996); (2) much larger tissue sample (entire intestine
with GALT) relative to ex vivo samples (2–3 mm2 biopsy speci-
mens) (Hicks et al., 1996); (3) mechanisms contributing to human
GALT genesis can be studied; (4) permits interorgan cell migra-
tion patterns to and from GALT; (5) physiological methods to
induce GALT pathogenesis (e.g., mucosal HIV transmission;
Sun et al., 2007); (6) multiple organs can be harvested simulta-
neously facilitating comparative analyses with GALT; and (7)
human GALT cells exposed to human pathogens in vivo can
be targeted by human therapeutics. To gain these experimental
advantages in GALT research, we bioengineered an appropriate
xenotransplantation model.
In mice, cryptopatches serve as anlagen for the postnatal
formation of ILFs (Eberl, 2005; Eberl and Littman, 2004; van deof Human Immunoglobulin-Producing Cells
gM, hIgG, or hIgA (green, left column) and anti-hCD45 (red, center column). The
igher-magnification images are presented under the original low-magnification
ted using Definiens Tissue Studio to quantitate the numbers of hCD45
+ cells
data sets). Data represent mean ± SEM.
Figure 5. hIgA-Secreting Cells Are the Most Common Plasma Cells Found in the SIs of N/S-BLT Mice
(A and B) Mononuclear cells isolated from the SIs of N/S-BLT (n = 4) and NSG-BLT (n = 4) mice were used for ELISPOT analyses to quantitate antibody-secreting
plasma cells (ASCs). (A) Images from a representative mouse per group are shown. (B) Cells secreting each immunoglobulin from each type of BLT mouse were
compared by Student’s t test (lines connect compared data sets). Data represent mean ± SEM.
(C) Fully differentiated hIgA
+ plasma cells in the SI lamina propria of N/S-BLT mice express hCD138, hCD27, and hCD38, but not hCD20 or HLA-DR. Images are
hIgA (green, left), hCD138, hCD20, hCD27, hCD38, or HLA-DR (red, center) and merged plus DAPI (right).
(legend continued on next page)
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Pavert and Mebius, 2010). This information, coupled with the
recent description of cryptopatch-like structures in human intes-
tines (Lu¨gering et al., 2010), led us to hypothesize that mouse
cryptopatches may serve as anlagen for human GALT genesis.
To test this hypothesis, we needed strains of immunodeficient
mice with or without cryptopatches in their GI tract and a human-
ization strategy that would result in the in situ development and
systemic dissemination, including throughout the GI tract, of
human hematopoietic cells. We identified two closely related
immunodeficient mouse strains (N/S and NSG) that differ genet-
ically only at the IL-2Rg chain locus, leading to a differential
phenotype in their ability to develop cryptopatches. Of the mul-
tiple strategies described for the humanization of immunodefi-
cient mouse strains (Denton and Garcı´a, 2011; Shultz et al.,
2007, 2012), BLT humanization was chosen because it results
in development of human T cells in N/S mice (Melkus et al.,
2006) and reproducible human reconstitution of mouse intes-
tines (Denton et al., 2012). This information combined with the
lack of detailed information regarding human GALT structure
development in BLT mice led us to utilize the BLT humanization
strategy coupled with the utilization of the N/S and NSG mouse
strains to test our hypothesis that mouse cryptopatches may
also serve as anlagen for human GALT genesis.
Confirming our hypothesis, a major finding of these studies is
the demonstration that endogenous cryptopatches in the SIs of
N/S mice serve as anlagen for the development of human GALT
structures following BLT humanization (Figure 2). These GALT
structures contain human T cells, B cells, dendritic cells, and
macrophages (Figure 3), indicating that homing molecules pro-
duced by mouse LTo cells in cryptopatches cross-react suffi-
ciently with their corresponding receptors on human hemato-
poietic cells to induce GALT formation. The critical role for
cryptopatches in human GALT development is highlighted by
the fact that cryptopatch-lacking NSG-BLT mice do not develop
human GALT structures (Figure 2). The abundance of human
T cells, B cells, dendritic cells, andmacrophages in all peripheral
tissues of NSG-BLT mice (Denton et al., 2012) does not rescue
the GALT-deficient phenotype in these animals. These observa-
tions represent a fundamental breakthrough in our mechanistic
understanding of the role of cryptopatches in human GALT
genesis.
A secondmajor finding is that humanB cells in theGALT struc-
tures of N/S-BLT mice recapitulate essential roles of B cells pre-
sent in human GALT (He et al., 2007; Spencer et al., 2012). As in
human intestines (He et al., 2007; Mestecky et al., 1999; Spencer
et al., 2012), in N/S-BLT mice, hIgA1
+ and hIgA2
+ cells are pre-
sent in both the GALT structures and the lamina propria (Fig-
ure 5). A difference we noted was a slightly inverted ratio of
hIgA1
+ and hIgA2
+ cells relative to human data (Figure S4) (He
et al., 2007; Mestecky et al., 1999; Spencer et al., 2012). This
could be due to either the chimeric intestinal environment and/or
the differential commensal microbiota between humans and
mice (Denton and Garcı´a, 2011; Shultz et al., 2007, 2012; Turn-(D) hIgA1- and hIgA2-producing plasma cells are found in both the human GALT
anti-hIgAwith binding specificities for both hIgA1 and hIgA2 (green, left), monoclon
DAPI (right).
Scale bars, 50 mm. See also Figure S4.
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ilarities between GALT structures of N/S-BLT mice and human
GALT.
In conclusion, here, we modeled human GALT development
and pathogenesis in vivo using a human-mouse chimeric model.
Key mechanistic discoveries include the demonstration that
mouse cryptopatches can initiate human GALT genesis, demon-
stration that human intestinal IgA production is initiated in the
GALT structures, and the depletion of human CD4+ T cells in
the GALT structures as a result of HIV infection. Our findings
have significant potential to stimulate further research on GALT
damage or malfunction as observed in HIV disease and IBDs.
The histology-based analyses of the GALT structures present
in HIV-infected N/S-BLTmice presented here exemplify possible
analyses in this model, which is the most comprehensive exp-
erimental platform currently available for the study and the
preclinical efficacy testing of therapeutics designed to repair
disease-damaged GALT.
EXPERIMENTAL PROCEDURES
Human-Mouse Chimeric Model
N/S (NOD.CB17-Prkdcscid/J), NSG (NOD.Cg-PrkdcscidIl2rgtm1Wjl/Szj), and
BALB/c mice were obtained from The Jackson Laboratory. All mice were
maintained either at the Division of Laboratory Animal Medicine at the Univer-
sity of North Carolina at Chapel Hill or the Animal Resources Center at the
University of Texas Southwestern Medical Center at Dallas in accordance
with protocols approved by each institution’s Institutional Animal Care and
Use Committee. N/S-BLT (n = 13) or NSG-BLT (n = 13) mice were prepared
essentially as previously described (Denton et al., 2012; Melkus et al., 2006).
Tissue for implantation was obtained from Advanced Bioscience Resources.
Human reconstitution in the peripheral blood of BLT mice was monitored by
polychromatic flow cytometry with the directly conjugated antibodies
described in Table S1.
Histological and Cellular Analyses
SIs, large intestines, MLNs, spleens, livers, and lungs were harvested, fixed
with 4% paraformaldehyde (Sigma-Aldrich), and embedded in either paraffin
(Leica) or OCT compound (Sakura). Tissue sections (5 mm) were analyzed as
detailed in the Extended Experimental Procedures. Antibodies utilized for his-
tological analyses are described in Tables S2 and S3. SIs of BLT mice and
control BALB/c mice were processed to isolate lamina propria mononuclear
cells essentially as previously described by Sun et al. (2007). Cells were utilized
for ELISPOT as detailed in the Extended Experimental Procedure. All statistical
analyses (a level, 0.05) were performed in Prism version 5 (GraphPad).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2013.05.037.
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provided the original author and source are credited.structures and the lamina propria of N/S-BLT mice. Images include polyclonal
al antibodies specific for either hIgA1 or hIgA2 (red, center), and themerged plus
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